Other Funding Opportunities

In addition to the Pilot Programs, CWRU’s CTSC regularly solicits proposals for other funding opportunities from NIH’s National Center for Advancing Translational Sciences (NCATS) throughout the year. Some current opportunities are described below. These lists are regularly reviewed and updated.


If you are interested in applying for one of these opportunities, contact Susan Connor, PhD, the CTSC’s Assistant Director of Research Programs.


CTSA Collaborations

  • PAR-22-167: Clinical and Translational Science Award (CTSA) Program: Collaborative and Innovative Acceleration Award (UG3/UH3 Clinical Trial Optional). Next due date February 15, 2023.
  • PAR-20-301: Drug Development Collaboratory (UG3/UH3 Clinical Trial Required). Next due date February 29, 2023.
  • PAR-22-122: Clinical and Translational Science Awards (CTSA) Consortium-Wide Centers: Resources for Rapid Demonstration and Dissemination (U24 Clinical Trials Optional). Next due date June 21, 2023.

See a full list of NCATS funding opportunities

Centers of Excellence/Research Hubs

  • RFA-OD-23-005: NIH Research Evaluation and Commercialization Hubs (REACH) Awards (U01 Clinical Trial Optional). Due date February 9, 2023.
  • RFA-HL-24-003. Programs for Inclusion and Diversity Among Individuals Engaged in Health-Related Research (PRIDE) Coordination Center (U24 Clinical Trial Not Allowed). Due date March 10, 2023.
  • RFA-TR-23-001: Translational Centers for Microphysiological Systems (TraCe MPS) (U2C Clinical Trials Not Allowed). Due date March 27, 2023.
  • HRSA-23-083: Life Course Translational Research Network (LCT-RN). Due date April 10, 2023.

Cancer

  • PAR-22-216: NCI Clinical and Translational Exploratory/Developmental Studies (R21 Clinical Trial Optional). Next due date February 13, 2023.

Environmental Influences on Child Health Outcomes (ECHO)

Environmental Research

  • RFA-ES-21-007. Virtual Consortium for Translational/Transdisciplinary Environmental Research (ViCTER) (R01 Clinical Trial Optional). Next due date February 1, 2023.

Exploratory/Developmental Research

  • PAR-20-168: Research on Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) (R21 Clinical Trials Not Allowed). Next due date February 16, 2023.

HEAL (Helping to End Addiction Long-term) Initiative

  • RFA-NS-22-034: HEAL Initiative: Discovery and Validation of Novel Targets for Safe and Effective Pain Treatment (R01 Clinical Trial Not Allowed). Next due date February 2, 2023.
  • PAR-22-058: HEAL Initiative: Translational Science Career Enhancement Awards for Early and Mid-career Investigators (K18 Clinical Trials Not Allowed). Next due date May 1, 2023.
  • RFA-TR-22-013: New Innovator Award (DP2). Next due date May 22, 2023.
  • RFA-TR-22-011: Early Stage Discovery of New Pain and Opioid Use Disorder Targets Within the Understudied Druggable Proteome (R21). Next due date May 22, 2023.
  • RFA-NS-21-015: Team Research for Initial Translational Efforts in Non-addictive Analgesic Therapeutics Development (U19 Clinical Trial Not Allowed). Next due date June 9, 2023.
  • RFA-EB-22-002: Translational Development of Diagnostic and Therapeutic Devices (R18 Clinical Trial Not Allowed). Next due date June 19, 2023.

HIV

  • RFA-HD-24-006: Using Archived Data and Specimen Collections to Advance Maternal and Pediatric HIV/AIDS Research (R21 - Clinical Trial Not Allowed). Due date March 29, 2023.
  • RFA-CA-22-057: Basic/Translational Research on Health Disparities in Underrepresented People Living with HIV (PLWH) and Cancer (R21 Clinical Trial Not Allowed). Next due date May 7, 2023.
  • RFA-CA-22-056: Basic/Translational Research on Health Disparities in Underrepresented People Living with HIV (PLWH) and Cancer (R01 Clinical Trial Not Allowed). Next due date May 7, 2023.

KL2 Scholars

  • PAR-21-121: Limited Competition: Small Grant Program for the NCATS Clinical and Translational Science Award (CTSA) Program (R03 Clinical Trial Optional). Next due data February 17, 2023.

Maternal Health Research Centers of Excellence

  • RFA-HD-23-037: Implementation Science Hub/Resource Center (U24)
  • RFA-HD-23-036: Data Innovation and Coordinating Hub/Resource Center (U24)
  • RFA-HD-23-035: Maternal Health Research Centers of Excellence (U54)

Mental Health

  • PAR-23-087: Novel Assays to Address Translational Gaps in Treatment Development (UG3/UH3 Clinical Trial Optional). Next due date February 21, 2023.

Neurological Disorders

  • PAR-20-168: Research on Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) (R21 Clinical Trials Not Allowed). Next due date February 16, 2023.
  • PAR-21-123: Innovation Grants to Nurture Initial Translational Efforts (IGNITE): Development and Validation of Model Systems to Facilitate Neurotherapeutic Discovery (R61/R33 Clinical Trial Not Allowed). Next due date February 21, 2023.
  • RFA-NS-21-021: Translational Neural Devices (UG3/UH3 - Clinical Trial Optional). Next due date February 21, 2023.

Patient-Centered Outcomes Research Institute (PCORI)

Populations Underrepresented in Research

  • RFA-PM-23-001: Enhancing the Use of the All of Us Research Program’s Data (R21 Clinical Trial Not Allowed). Due date March 1, 2023.
  • RFA-PM-23-002: Small Grants to Enhance the Use of the All of Us Research Program’s Data (R03 Clinical Trial Not Allowed). Due date March 1, 2023.

Rare Diseases

  • PAR-22-184: Clinical Trial Readiness for Rare Neurological and Neuromuscular Diseases (U01 Clinical Trial Not Allowed). Next due date February 17, 2023.
  • RFA-TR-22-030: Pilot Projects Investigating Understudied Proteins Associated with Rare Diseases (R03). Next due date March 15, 2023
  • PAR-22-101: Clinical Trial Readiness for Rare Diseases, Disorders, and Syndromes (R21 Clinical Trial Not Allowed). Next due date May 15, 2023

Other Translational Research Opportunities

  • PAR-20-156: Translational Bioinformatics Approaches to Advance Drug Repositioning and Combination Therapy Development for Alzheimer’s Disease (R01 Clinical Trial Optional). Next due date February 5, 2023.
  • PAR-22-216: NCI Clinical and Translational Exploratory/Developmental Studies (R21 Clinical Trial Optional). Next due date February 13, 2023.
  • PAR-22-169: Novel Assays to Address Translational Gaps in [Mental Health] Treatment Development (UG3/UH3 Clinical Trial Optional). Next due date February 21, 2023.
  • RFA-DA-24-010: Rapid Translation of Epidemiological Findings into Interventions to Prevent Substance Use and Addiction (R61/R33 - Clinical Trial Optional). Next due date March 15, 2023. 

Search for Funding

Pilot Program funding should lead to funding from government agencies and private foundations. Explore the links below to find the right funding opportunities to take your Pilot Project to the next stage.

NIH NIH is the world’s largest funder of biomedical research. Search NIH’s funding list and learn about grants and other resources.
National Science Foundation Browse the NSF’s current funding opportunities.
Department of Defense The Congressionally Directed Medical Research Program has a variety of funding opportunities focused on transforming healthcare through innovative and impactful research.
Grants.gov

Grants.gov is a centralized location for grant seekers to find and apply for funding opportunities from all departments of the federal government.

Foundations CWRU subscribes to Pivot, a service available to all faculty, staff researchers, and graduate students that helps you quickly discover the right funding opportunities. Follow the link above for the Office of Research & Grant Development’s quick start guide.